Abstract:Highlights • A set of nine selected agents were first tested for their effects on the premature aging of the hematopoietic system in total body irradiated (TBI) mice. • 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside (TSG) was successfully identified as a potent rejuvenating agent for aging HSCs. • TSG treatment significantly increased the absolute number of common lymphoid progenitors (CLPs) along with their downstream B lymphocytes both in TBI mice and naturally aging mice. • TSG treatment boosted the HSCs/CLPs repopulation potential of aging mice without causing any significant adverse effects. • TSG supplementation restored the loss of regenerative capacity and decline in lymphopoiesis via AMPK-Tet2 axis. Introduction Aging of hematopoietic stem cells (HSCs) has emerged as an important challenge to human health. Recent advances have raised the prospect of rejuvenating aging HSCs via specific medical interventions, including pharmacological treatments. Nonetheless, efforts to develop such drugs are still in infancy until now. Objectives We aimed to screen the prospective agents that can rejuvenate aging HSCs and explore the potential mechanisms. Methods We screened a set of natural anti-aging compounds through oral administration to sub-lethally irradiated mice, and identified 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside (TSG) as a potent rejuvenating agent for aging HSCs. Then naturally aged mice were used for the follow-up assessment to determine the HSC rejuvenating potential of TSG. Finally, based on the transcriptome and DNA methylation analysis, we validated the role of the AMP-activated protein kinase (AMPK)-ten-eleven-translocation 2 (Tet2) axis (the AMPK-Tet2 axis) as the underlying mechanisms of TSG for ameliorating HSCs aging. Results TSG treatment not only significantly increased the absolute number of common lymphoid progenitors (CLPs) along with B lymphocytes, but also boosted the HSCs/CLPs repopulation potential of aging mice. Further elaborated mechanism research demonstrated that TSG supplementation restored the stemness of aging HSCs, as well as promoted an epigenetic reprograming that was associated with an improved regenerative capacity and an increased rate of lymphopoiesis. Such effects were diminished when the mice were co-treated with an AMPK inhibitor, or when it was performed in Tet2 knockout mice as well as senescent cells assay. Conclusion TSG is effective in rejuvenating aging HSCs by modulating the AMPK- Tet2 axis and thus represents a potential candidate for developing effective HSC rejuvenating therapies. Graphical abstract Download : Download high-res image (241KB) Download : Download full-size image

Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2

Mutual Regulation Between GDF11 and TET2 Prevents Senescence of Mesenchymal Stem Cells

Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice

Tetrahydroxystilbene Glucoside Delayed Senile Symptoms in Old Mice via Regulation of the AMPK/SIRT1/PGC-1α Signaling Cascade

Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging

Angelica sinensis polysaccharides prevents hematopoietic regression in D-Galactose-Induced aging model via attenuation of oxidative stress in hematopoietic microenvironment

Mechanisms and rejuvenation strategies for aged hematopoietic stem cells

Taurine postponed the replicative senescence of rat bone marrow-derived multipotent stromal cells in vitro

Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation

Local Delivery of Tetramethylpyrazine Eliminates the Senescent Phenotype of Bone Marrow Mesenchymal Stromal Cells and Creates an Anti-Inflammatory and Angiogenic Environment in Aging Mice

Secretome of Human Fetal Mesenchymal Stem Cell Ameliorates Replicative Senescence

Mtor Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

Protective Effect of Tetrahydroxystilbene Glucoside Against D-Galactose Induced Aging Process in Mice

Protective Effect of Ginsenoside Rg1 on Hematopoietic Stem/Progenitor Cells through Attenuating Oxidative Stress and the Wnt/β-Catenin Signaling Pathway in a Mouse Model of d-Galactose-induced Aging

Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions

Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice

A metabolic atlas of blood cells in young and aged mice identifies uridine as a metabolite to rejuvenate aged hematopoietic stem cells

Transcriptome and lipidome profile of human mesenchymal stem cells with reduced senescence and increased trilineage differentiation ability upon drug treatment

Advancing immunomodulatory functions in mesenchymal stem/stromal cells through targeting the GATA6-mediated pathway

The aging-delay effects of ginsenoside Rg 1 on hemopoietic stem and progenitor cell are related with changes of cell cycle regulating molecule expression

Long‐term mid‐onset dietary restriction rejuvenates hematopoietic stem cells and improves regeneration capacity of total bone marrow from aged mice